ProCure was founded in 2005 by John Cameron, PhD, a particle physicist who is among the pioneers in proton therapy. Dr. Cameron was instrumental in the development of the Midwest Proton Radiotherapy Institute (now IU Health Proton Therapy Center), the third proton therapy center to open in the United States. ProCure was founded to carry out his mission: To improve the lives of patients with cancer by increasing access to proton therapy.
Dr. Cameron brought together a skilled senior management team of proton therapy experts who had been involved in the construction and operation of centers in the United States and internationally.
Today, ProCure is the only company in the world with 2 centers open and treating patients. The ProCure Proton Therapy Center in Oklahoma City, Oklahoma, opened in July 2009 and the ProCure Proton Therapy Center in Somerset, New Jersey, opened in March 2012.
ProCure Treatment Centers, Inc. founded by John Cameron, PhD
- september 20
Groundbreaking for the ProCure Training and Development Center, Bloomington, Ind.
- April 9
Groundbreaking for the ProCure Proton Therapy Center, Oklahoma City.
- February 14
ProCure announces collaboration with the University of Pennsylvania’s Roberts Proton Therapy Center to advance proton therapy training, research and development. ProCure’s network of centers are linked into UPENN’s research protocols. March 27
The ProCure Proton Therapy Training and Development Center opens - the world’s first and only facility dedicated exclusively to proton therapy training and certification. April 7
ProCure announces collaboration with IVY Tech Community College, Bloomington, Ind., offering a proton therapy certificate program for students enrolled in the College’s Radiation Therapy Program. May 12
The ProCure Proton Therapy Center in Oklahoma City receives its 220-ton cyclotron, the core piece of equipment used in proton therapy – en-route to a world record 27-month construction timeline. May 14
ProCure receives an additional $35 million round of equity funding from Oklahoma City-based McClendon Venture Company, LLC (MVC). July 9
ProCure and William Beaumont Hospital, Royal Oaks, Mich., a suburb of Detroit, receive Certificate of Need approval from the Michigan Department of Community Health to build a proton therapy center. August 20
ProCure is recognized as an Indiana Company to Watch, an award that recognizes the 50 top privately held second-stage companies in Indiana. October 29
ProCure announces collaboration with Oklahoma State University to create undergraduate and graduate programs in medical physics to train the next generation of medical professionals in delivering proton therapy.
- February 19
First group of physicians, physicists, dosimetrists begin training at ProCure’s Training and Development Center. July 8
The ProCure Proton Therapy Center opens in Oklahoma City. November 12
First group of patients complete treatment at the ProCure Proton Therapy Center in Oklahoma City.
- April 7
Groundbreaking for the ProCure Proton Therapy Center in Somerset, N.J. April 13
ProCure Proton Therapy Center in Oklahoma City becomes first in the world to use ProCure-designed inclined beam technology. July 8
The ProCure Proton Therapy Center in Oklahoma City celebrates one year anniversary. July 16
INTEGRIS Cancer Institute of Oklahoma and the ProCure Proton Therapy Center in Oklahoma City announce a breakthrough treatment approach for anal canal cancer.
- February 1
ProCure receives an additional $40 million round of equity funding, led by Maverick Capital. March 1
ProCure Proton Therapy Center in Somerset, N.J., receives its cyclotron. May 10
ProCure announces the hiring of Chief Medical Officer Eugen B. Hug, M.D., internationally renowned radiation oncologist and proton therapy expert. September 17
The ProCure Proton Therapy Center in Oklahoma City celebrates 500 patients treated.
- March 20
ProCure Proton Therapy Center in Somerset, N.J., opens.
- back to the topGo Top